NCT02062294 An Observational Study of Valcyte (Valganciclovir) in D+/R- Liver Transplant Recipients Status COMPLETED Phase N/A
NCT02055820 A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL Status COMPLETED Phase PHASE1/PHASE2
NCT02053610 CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 2) Status COMPLETED Phase PHASE3
NCT02051608 A Study of Gantenerumab in Participants With Mild Alzheimer Disease Status COMPLETED Phase PHASE3
NCT02046616 A Study of Subcutaneous (SC) Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis (RA) and Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs (DMARDs) Status COMPLETED Phase PHASE3
NCT02046603 A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent Status COMPLETED Phase PHASE3
NCT02044029 Ability of Muscle Imaging and Motor Function Measure (MFM) to Detect Changes in Disease Progression in Ambulant Spinal Muscular Atrophy Patients Compared to Healthy Volunteers. Status COMPLETED Phase N/A
NCT02042833 An Observational Study of Patients' Perception of Treatment With Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease Not on Dialysis (PERCEPOLIS) Status COMPLETED Phase N/A
NCT02040935 A Study of SC Administration of Trastuzumab (Herceptin) by SID at Home in HER2-Positive EBC Participants Status COMPLETED Phase PHASE3
NCT02031744 A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT02031731 The Pharmacokinetics and Safety of Onartuzumab (MetMAb) in Chinese Patients With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT02031471 TOSCARA Study: A Study of Subcutaneous Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis Naïve to RoActemra/Actemra Treatment Status COMPLETED Phase PHASE3
NCT02031458 A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT02028884 Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) Status COMPLETED Phase PHASE3
NCT02024789 A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) Status COMPLETED Phase PHASE2
NCT02023125 A Study Investigating the Effect of Food and Esomeprazole on the Single Oral Dose Pharmacokinetics of Alectinib (RO5424802) in Healthy Volunteers. Status COMPLETED Phase PHASE1
NCT02022917 Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer Status COMPLETED Phase PHASE2
NCT02019329 A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone Status COMPLETED Phase PHASE1
NCT02019290 A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers. Status WITHDRAWN Phase PHASE1
NCT02019277 A Study of Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE3